| 產(chǎn)品名稱 | AZD 8330 |
| 產(chǎn)品貨號 | Axon 1999 CAS [869357-68-6] MF C16H17FIN3O4MW 461.23 Purity: 98% Soluble in DMSO Description Potent, highly specific non-ATP-competitive MEK inhibitor; AZD8330 specifically inhibits mitogen-activated protein kinase kinase 1 (MEK or MAP/ERK kinase1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation References Certificates Categories Extra info JI Trujillo. MEK inhibitors: a patent review 2008-2010. Exp. Opin. Ther. Patents. 2011, 21(7), 1045-1069.? ? MS Chapman & JN Miner. Novel mitogen-activated protein kinase kinase inhibitors. Exp. Opin. Invest. Drugs. 2011, 20(2), 209-220.? ? C Frémin and S Meloche. From basic research to clinical development of MEK1/2 inhibitors for cancer therapy. J. Hematol. Oncol. 2010, 3, 8.?? Certificate of Analysis Material Safety Data Sheet Cell Signaling & Oncology MAPK EC 2.7.12.2 MEK MEK 1 inhibitor Chemical name 2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide Parent CAS No. [869357-68-6] Order Size Unit Price Stock 5 mg €105.00 In Stock |
| 產(chǎn)品價(jià)格 | 現(xiàn)貨詢價(jià)，電話：010-67529703 |
| 產(chǎn)品規(guī)格 | |
| 產(chǎn)品品牌 | axonmedchem |
| 產(chǎn)品概述 | |
| 產(chǎn)品詳情 |
AZD 8330Axon 1999 CAS [869357-68-6] MF C16H17FIN3O4
Description
Potent, highly specific non-ATP-competitive MEK inhibitor; AZD8330 specifically inhibits mitogen-activated protein kinase kinase 1 (MEK or MAP/ERK kinase1), resulting in inhibition of growth factor-mediated cell signaling and tumor cell proliferation
MEK 1 inhibitor
Chemical name2-(2-fluoro-4-iodophenylamino)-N-(2-hydroxyethoxy)-1,5-dimethyl-6-oxo-1,6-dihydropyridine-3-carboxamide Parent CAS No.[869357-68-6] |
| 產(chǎn)品資料 |
